rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-5-10
|
pubmed:abstractText |
Despite the pluripotency of embryonic stem (ES) cells, their clinical applications have been hindered due to the lack of reliable differentiation methods. Recently, it was shown that Noggin could effectively induce cardiomyocyte differentiation by transient treatment of ES cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1874-1754
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
141
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-60
|
pubmed:meshHeading |
pubmed-meshheading:19138802-Animals,
pubmed-meshheading:19138802-Carrier Proteins,
pubmed-meshheading:19138802-Cell Differentiation,
pubmed-meshheading:19138802-Cells, Cultured,
pubmed-meshheading:19138802-Embryonic Stem Cells,
pubmed-meshheading:19138802-Hydroxamic Acids,
pubmed-meshheading:19138802-Matrix Metalloproteinase 3,
pubmed-meshheading:19138802-Mice,
pubmed-meshheading:19138802-Myocytes, Cardiac,
pubmed-meshheading:19138802-Oligopeptides,
pubmed-meshheading:19138802-Up-Regulation
|
pubmed:year |
2010
|
pubmed:articleTitle |
Association of matrix metalloproteinase-3 with cardiogenic activity during Noggin-induced differentiation of mouse embryonic stem cells.
|
pubmed:affiliation |
Macrogen Inc, World Meridian Venture Center, 60-24 Gasan-dong, Seoul 153-023, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|